Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Green Brick Partners
GRBK
$3.07B
| $1.07M | ﹤0.01% |
18,737
-23,191
| -55% | -$1.3M |
|
|
BBT
2477
Beacon Financial Corp
BBT
$2.67B
| $1.07M | ﹤0.01% |
47,024
-24,703
| -34% | -$542K |
|
|
BBBY
2478
Bed Bath & Beyond
BBBY
$429M
| $1.07M | ﹤0.01% |
90,082
+34,350
| +62% | +$610K |
|
2479
Arcturus Therapeutics
ARCT
$173M
| $1.06M | ﹤0.01% |
43,501
+7,757
| +22% | +$235K |
|
2480
ESCO Technologies
ESE
$8.5B
| $1.06M | ﹤0.01% |
10,073
-13,568
| -57% | -$1.43M |
|
2481
Hecla Mining
HL
$10.7B
| $1.06M | ﹤0.01% |
217,949
-337,179
| -61% | -$1.8M |
|
2482
GitLab
GTLB
$6.03B
| $1.06M | ﹤0.01% |
21,248
-5,125
| -19% | -$266K |
|
2483
CALL
Realty Income
O
$58.2B
| $1.06M | ﹤0.01% |
+20,000
| New | +$1.07M |
|
2484
Envista
NVST
$4.46B
| $1.06M | ﹤0.01% |
63,518
-127,200
| -67% | -$2.4M |
|
2485
First Bancorp
FBNC
$2.66B
| $1.05M | ﹤0.01% |
32,976
-25,698
| -44% | -$817K |
|
2486
CALL
Capri Holdings
CPRI
$1.72B
| $1.05M | ﹤0.01% |
+31,700
| New | +$1.15M |
|
2487
Marten Transport
MRTN
$1.21B
| $1.05M | ﹤0.01% |
56,809
-32,579
| -36% | -$571K |
|
2488
Virtus Investment Partners
VRTS
$1.09B
| $1.05M | ﹤0.01% |
4,631
-2,988
| -39% | -$680K |
|
2489
MGE Energy Inc
MGEE
$3.05B
| $1.04M | ﹤0.01% |
13,978
-18,908
| -57% | -$1.48M |
|
2490
ArcBest
ARCB
$3.02B
| $1.04M | ﹤0.01% |
9,748
-14,586
| -60% | -$1.76M |
|
2491
REX American Resources
REX
$1.43B
| $1.04M | ﹤0.01% |
45,756
+16,428
| +56% | +$438K |
|
2492
Globalstar
GSAT
$10.7B
| $1.04M | ﹤0.01% |
61,998
-26,645
| -30% | -$480K |
|
2493
CALL
Shoals Technologies Group
SHLS
$1.45B
| $1.04M | ﹤0.01% |
+166,700
| New | +$1.33M |
|
2494
White Mountains Insurance
WTM
$5.3B
| $1.04M | ﹤0.01% |
570
-437
| -43% | -$773K |
|
2495
Capital City Bank Group
CCBG
$894M
| $1.03M | ﹤0.01% |
36,380
-7,265
| -17% | -$197K |
|
|
PFC
2496
DELISTED
Premier Financial Corp. Common Stock
PFC
| $1.03M | ﹤0.01% |
50,549
-22,513
| -31% | -$447K |
|
2497
Mueller Water Products
MWA
$4.24B
| $1.03M | ﹤0.01% |
57,653
-85,109
| -60% | -$1.46M |
|
2498
CALL
Beam Therapeutics
BEAM
$2.81B
| $1.03M | ﹤0.01% |
44,000
-3,000
| -6% | -$73.7K |
|
2499
Fox Factory Holding Corp
FOXF
$791M
| $1.03M | ﹤0.01% |
21,369
-52,903
| -71% | -$2.39M |
|
2500
Stevanato
STVN
$5.54B
| $1.03M | ﹤0.01% |
56,100
-145,150
| -72% | -$3.38M |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.